Concepedia

Mi Tang

MT

5

Publications

130

Citations

5

H-Index

2016

Active since

Affiliations

Chinese Academy of Sciences(Current)

Jiangsu Hengrui Medicine (China)

Mi Tang is an author at Chinese Academy of Sciences specializing in drug discovery, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2016–2023

5

Publications

5

SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models

Changyong Yang, Lei Wang, Xing Sun et al. · Acta Pharmacologica Sinica · 2019 · 44 citations · Full text

, , +11

CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone

Mi Tang, Huang Chen, Yufei Wang et al. · Scientific Reports · 2016 · 35 citations · Full text

The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury

Mi Tang, Quansheng Su, Yimei Duan et al. · Scientific Reports · 2023 · 21 citations · Full text

Discovery of A Novel EGFR-Targeting Antibody–Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies

Kaijie He, Jianyan Xu, Jindong Liang et al. · Molecular Cancer Therapeutics · 2019 · 17 citations · Full text

Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study

Jianghui Cai, Mi Tang, Hong Xi Zhang et al. · Jornal de Pediatria · 2022 · 13 citations · Full text

Rows per page

1–5 of 5